Hefei Hengxin Life Science and Technology plans to invest 10 million yuan to participate in the subscription of CGC Golden He Fund shares.

Hefei Hengxin Life Science and Technology (301501.SZ) announced that, according to the company's strategic planning needs, in order to further expand the company's business scope, better leverage the professional strength and resource advantages of professional institutions, integrate various resources, obtain long-term investment returns, and enhance the company's overall competitiveness, the company plans to cooperate with the professional investment institution Beijing Fangyuan Jinding Investment Management Co., Ltd. (referred to as "Beijing Jinding", fund manager, general partner, and executive partner) and other limited partners, to jointly invest. The company plans to participate as a limited partner with its own capital of 10 million yuan, in subscribing to the fund shares of Gongqingcheng Jinyi Entrepreneurial Investment Partnership Enterprise (Limited Partnership) (referred to as "Gongqingcheng Jinyi"). The investment direction of this partnership enterprise is a single investment target, through equity investment in Taileyuan to achieve capital appreciation of the partnership enterprise. By jointly investing with professional investment institutions this time, and ensuring the stable development of the company's main business, the company can utilize the resources and advantages of professional investment institutions in the field of equity investment, engage in investment business, improve the efficiency of capital operation of the company, further enhance the overall competitiveness and profitability of the company.